MedMind Technology Co., Ltd.
PrivateLast Round
Series C
Extension
Sep 1, 2022
Total Funding Raised
$10.93M
Company Overview
MedMind Technology Co., Ltd. operates in Healthcare & Life Sciences and is based in Beijing. Its latest recorded funding round was a Series C Extension round in September 2022.
MedMind Technology Co., Ltd. is a medical technology company that develops deep learning-based AI software for radiation oncology, including automatic contouring of tumor targets and organs at risk.
Sector
Healthcare & Life Sciences
Verticals
Medical AI, Medical Imaging, Computer Vision, Workflow Automation
Business Model
B2B
Customer Profile
Subscription SaaS, Services & Consulting
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
MedMind Technology Co., Ltd. Comparables
Compare MedMind Technology Co., Ltd. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| LinkingMed | 92% | |
| PVmed | 88% | |
| Manteia Technologies Co., Ltd. | 85% |
For institutional investors. Book with your work email.
MedMind Technology Co., Ltd. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series C Extension | Sep 1, 2022 | ||||
| Series C | Jun 21, 2021 | ||||
| Series A Extension | Apr 1, 2019 | ||||
| Series A | Nov 6, 2018 |
For institutional investors. Book with your work email.
MedMind Technology Co., Ltd. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Qingsong Fund | Series A Extension |
| Shanghai Shengyu Equity Investment Fund Management | Series C |
| Yijing Capital | Series C |
| BioTrack Capital | Series C |
| Cherami Investment Group | Series C Extension |
Market signals
Structured signals derived from secondary market and firmographic data.
- Sep 1, 2022
Cherami Investment Group participated in the round.
- Jun 21, 2021
Led by BioTrack Capital with participation from Shanghai Shengyu and Yijing Capital.
For institutional investors. Book with your work email.
MedMind Technology Co., Ltd. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about MedMind Technology Co., Ltd.'s valuation, stock price, and market status.
Is MedMind Technology Co., Ltd. a public or private company?
MedMind Technology Co., Ltd. is a private company.
What is the current stock price of MedMind Technology Co., Ltd.?
MedMind Technology Co., Ltd. is a private company, so its shares have no public market price. Caplight tracks MedMind Technology Co., Ltd.'s secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is MedMind Technology Co., Ltd. worth (valuation)?
Valuation information for MedMind Technology Co., Ltd. is not publicly available.
Can I buy MedMind Technology Co., Ltd. stock?
MedMind Technology Co., Ltd. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was MedMind Technology Co., Ltd.'s last funding round?
MedMind Technology Co., Ltd.'s most recent funding round was Series C Extension on September 1, 2022.
Who are the main investors in MedMind Technology Co., Ltd.?
Key investors in MedMind Technology Co., Ltd. include Qingsong Fund, BioTrack Capital.
Will MedMind Technology Co., Ltd. IPO soon?
No public IPO plans have been announced for MedMind Technology Co., Ltd..
How can I track MedMind Technology Co., Ltd. secondary market activity?
Caplight tracks bids, offers, and trades in MedMind Technology Co., Ltd.'s shares on secondary markets.